MS Speaks
Multiple Sclerosis => TREATMENTS => OCREVUS (ocrelizumab) => Topic started by: agate on December 26, 2017, 12:19:11 pm
-
JAMA interview (December 13, 2017) with Dr. Stephen Hauser and Dr. Jeffrey A. Cohen. Stephen Hauser, MD, of the University of California, San Francisco, led the development of ocrelizumab, and Jeffrey A. Cohen, MD, of the Cleveland Clinic, has been pursuing research into remyelination.
The focus of the discussion is on Ocrevus:
https://jamanetwork.com/journals/jama/fullarticle/2666528